Federal Case Details Alleged “Referral Loop” Behind Leigh Tesar’s Medicare Wound-Billing Racket
Prosecutors allege co-defendants supplied Medicare beneficiaries for high-cost allograft care, creating what may be described as a patient-feeder network, although the indictment itself calls them purported sales representatives rather than “feeders” in its formal charging language.
WASHINGTON, DC, August 22, 2026 — Federal prosecutors have placed an alleged patient-referral pipeline at the center of their case against Florida nurse practitioner Leigh Tesar, contending that access to Medicare beneficiaries with wounds became the indispensable fuel for an extraordinarily lucrative billing operation.
The accusation goes beyond disputed medical judgment because investigators say registered nurses Walter Presha Jr. and Koby Evans found potential patients, directed them to Tesar’s Sarasota practice, and received compensation allegedly based on the expensive wound products associated with those referrals.
According to the Justice Department’s official announcement and linked federal indictment, the defendants participated in an eighteen-month scheme that generated more than $118 million in Medicare claims, produced approximately $61 million in payments, and led authorities to seize roughly $11.8 million in assets.
Tesar, Presha, and Evans have been charged but not convicted; every accusation remains unproven, and each defendant is entitled to challenge the government’s witnesses, documents, financial analysis, medical conclusions, and interpretation of communications throughout the federal court process.
That presumption matters particularly when explaining a complex alleged “referral loop,” because an indictment presents the prosecution’s account rather than adjudicated facts, and apparently incriminating payments or messages can acquire different meanings after adversarial testing, fuller context, and defense evidence.
What Prosecutors Mean by the Alleged Referral Loop
The alleged loop began when Presha, Evans, or other purported representatives identified Medicare beneficiaries with wounds, continued when Tesar or Primecare provided costly allograft treatment, and closed when product-linked payments allegedly returned to the people responsible for supplying those patients.
Prosecutors contend the structure could then renew itself, because higher product costs produced larger alleged commissions, successful Medicare reimbursement supplied money throughout the chain, and patient access allowed additional treatments and claims to enter the same commercial cycle.
This theory makes recruitment inseparable from billing, since the government is not merely alleging that unnecessary products were selected after patients independently arrived, but that financially motivated sourcing allegedly steered beneficiaries into a treatment channel designed around highly reimbursable materials.
The indictment further connects individual patients, particular allografts, Primecare’s payments, designated representatives, distributor transfers, and Medicare claims, giving prosecutors a transactional map they may use to argue that referrals and reimbursements were coordinated components rather than unrelated business events.
“Feeders” Describes the Theory, Not the Indictment’s Vocabulary
The word “feeders” does not appear in the twenty-one-page indictment, and prosecutors formally identify Presha and Evans as registered nurses and “purported sales representatives” who allegedly referred beneficiaries in exchange for illegal bribes and kickbacks.
Describing them as patient feeders can summarize the functional role the government alleges, but responsible reporting should not present that vivid label as a quotation or official characterization from the charging document.
The same caution applies to “referral loop,” which is a useful analytical description of the alleged circular incentive structure, although the indictment itself speaks in conventional legal terms about a conspiracy, false claims, remuneration, referrals, concealment, and personal enrichment.
Clarifying that distinction strengthens the account rather than weakening it, because readers can separate the document’s actual allegations from explanatory language used to make a complicated network of patients, practitioners, suppliers, products, claims, and payments understandable.
The People and Businesses Inside the Alleged Pipeline
The indictment identifies Tesar as a Sarasota County nurse practitioner who operated Tesar Primecare, a Florida business registered with Medicare as a single- or multispecialty clinic or group practice, and created the billing platform through which the disputed claims allegedly traveled.
Presha, an Ellenton-area registered nurse, allegedly owned Universal Nursing and Wellness and registered W.P. Enterprises as a fictitious business name, while Evans, an Apollo Beach-area registered nurse, allegedly owned a separate Florida company called Healing His Way.
A Pennsylvania wound-product distributor, identified only as Company-I, allegedly sold and marketed allografts to Tesar and Primecare while engaging Presha, Evans, and others through agreements presenting them as sales representatives for the distributor’s products.
Prosecutors call those agreements shams, alleging that the supposed representatives were actually retained to locate Medicare beneficiaries with wounds and send them to Tesar, while Company-I’s account provided the financial channel through which referral compensation could be transmitted.
Patient Access Allegedly Became the Valuable Commodity
The case portrays Presha and Evans as valuable not primarily because they persuaded clinicians to purchase a product, but because their nursing positions, healthcare relationships, or patient contacts allegedly enabled them to identify people whose wounds could support expensive Medicare claims.
One January 2025 message described in the indictment introduced Evans to an owner of Company-I by saying he had “quite a few patients in mind,” language prosecutors will likely argue tied his commercial importance directly to ready access rather than product expertise.
An earlier exchange allegedly involved Tesar suggesting that she could move among rooms looking for wounds before adding that the approach “might be illegal,” a short statement whose meaning, context, audience, and admissibility will receive close scrutiny if the case reaches trial.
Together, those alleged messages allow the government to portray patient identification as an organized acquisition strategy, while the defense may contend that clinicians routinely locate untreated wounds, coordinate specialist care, and communicate informally without participating in a criminal referral enterprise.
The decisive question will not be whether Presha and Evans knew potential patients, but whether prosecutors can prove beyond a reasonable doubt that they knowingly exchanged referrals for prohibited remuneration and joined an agreement intended to corrupt federally reimbursed care.
A Twenty-Percent Formula Allegedly Connected Referrals to Products
The indictment describes a September 2024 message in which Tesar allegedly told Presha that his total invoices exceeded $4.06 million, applied a twenty-percent calculation, and sent a calculator image showing approximately $813,925 as the resulting figure.
That alleged formula is central because percentage compensation tied to invoiced products can expand as product prices, treated wound areas, or application volume increase, potentially rewarding patient sourcing far more aggressively than a fixed payment for legitimate marketing services.
In January 2025, Tesar allegedly told Evans that a new product cost $2,000 per square centimeter instead of $1,591 and explained that his twenty-percent share would rise as a result, directly linking the product’s price to his anticipated compensation.
The following day, prosecutors say Tesar sent Presha a similar message about significantly higher compensation and her intention to switch patients to the more expensive product, an allegation that may connect financial incentives with clinical product selection.
After discussing expected money with Evans in April 2025, Tesar allegedly warned him not to disclose that she had discussed payment information, which prosecutors may characterize as concealment while defense lawyers may contest the interpretation or surrounding circumstances.
Company-I Allegedly Closed the Financial Circuit
Prosecutors allege that Tesar emailed a Company-I owner in July 2025 with Primecare payments, particular allografts, associated patients, and assigned representatives, supplying the information allegedly needed to determine which patient source should receive compensation for which transaction.
On August 15, 2025, Company-I allegedly transferred approximately $397,570 into the W.P. Enterprises account associated with Presha and approximately $10,998 into the Healing His Way account associated with Evans, forming the basis for four substantive kickback counts.
The government will likely argue that the patient-specific accounting, percentage discussions, distributor agreements, and bank transfers reveal a deliberately disguised referral-payment system, because legitimate sales compensation ordinarily depends upon genuine sales work rather than delivery of federally insured patients.
The defendants may answer that the agreements reflected lawful commercial services, that compensation was not paid to induce referrals, or that disputed communications have innocent explanations, placing intent and the actual purpose of each payment at the center of litigation.
Why Medicare Beneficiaries Were Particularly Exposed
Medicare principally serves people aged sixty-five and older while also covering certain younger people with disabilities or end-stage renal disease, meaning the alleged pipeline drew from a population that can include medically fragile patients who depend heavily upon professional guidance.
A nurse’s recommendation may carry exceptional authority inside a home, facility, hospital room, or outpatient setting, and patients may reasonably assume that suggested treatment reflects independent clinical judgment rather than an undisclosed financial relationship connected to the practitioner receiving the referral.
Prosecutors also accuse Tesar and others of encouraging beneficiaries to start or continue allograft treatment by misrepresenting costs, unlawfully waiving copayments, providing free medical supplies, and distributing expensive gifts, allegedly including jewelry and a leather recliner.
Those inducement allegations matter under the referral-loop theory because financial benefits at both ends could allegedly reinforce participation, with patient sources receiving commissions while beneficiaries faced lower costs or received valuable items to stay in the treatment stream.
The Clinical Rules the Alleged Loop Had to Bypass
Allografts described in the case include bioengineered skin substitutes made from human placental tissue and applied over qualifying open wounds to encourage closure or skin growth, treatments that can be medically valuable when evidence-based coverage conditions are satisfied.
Florida’s Medicare contractor required continuing records showing wound improvement, accepted treatment standards, management of conditions affecting healing, and a duration reasonably correlated with the patient’s expected recovery, rather than repeated applications unsupported by measurable clinical progress.
For specified diabetic foot and venous leg ulcers, applicable coverage guidance generally required at least four documented weeks of unsuccessful conservative care, including measures such as debridement, pressure relief, infection control, and management of wound drainage before covered graft treatment.
The same guidance discouraged switching products during a defined treatment course, rejected repeated applications after an unsuccessful graft, and excluded certain patients with uncontrolled underlying conditions or active infections, requirements that restricted when high-cost materials could properly generate reimbursement.
Prosecutors allege Tesar nevertheless used products without confirming adequate conservative treatment, continued after wounds failed to respond, applied allografts to infected wounds or terminal patients whose wounds could not heal, and chose particular products solely to maximize profit.
Medical Records Allegedly Kept the Billing Cycle Moving
The government says Tesar and others falsified medical charts so disputed treatments appeared reasonable, necessary, and compliant, including entries asserting that services occurred when none were rendered and that conservative wound care had previously been administered.
Other records allegedly moved the documented onset of wounds to earlier dates or misstated patient conditions, changes that could make it appear that prerequisite treatment periods had elapsed and coverage criteria were satisfied before expensive applications began.
Because Medicare contractors often adjudicate claims based on codes, dates, certifications, and supporting records rather than personally observing care, accurate documentation serves as a critical control separating legitimate reimbursement from payments generated by fabricated or materially incomplete clinical narratives.
The indictment also alleges that Tesar removed her name from Primecare’s Florida ownership records after a Medicare audit while secretly retaining ownership and managerial control, conduct prosecutors characterize as an effort to evade scrutiny while billing continued.
Five Claims Illustrate the Alleged Billing Engine
The five substantive healthcare-fraud counts identify representative claims involving separate beneficiaries and billed amounts ranging from approximately $288,350 to more than $1.11 million, with Medicare payments ranging from about $199,769 to approximately $854,311.
Those examples do not independently establish that every claim within the broader $118 million total was fraudulent, but prosecutors can use selected transactions to show a recurring method and explain how patient sourcing, documentation, treatment, pricing, and payment allegedly interacted.
From approximately May 2024 through November 2025, the indictment says Medicare paid Tesar and Primecare more than $61 million for wound-care products and services allegedly unnecessary, unperformed, misrepresented, ineligible, or procured through kickbacks.
Local WWSB reporting on the federal charges independently summarized the same central allegations, including the billed and paid totals, the three defendants’ professional roles, the claimed referral payments, and the government’s seizure of approximately $11.8 million.
Fraud Proceeds Allegedly Funded Luxury Spending
Prosecutors allege that money generated through the operation funded more than $215,000 in spending on Tampa Bay Buccaneers tickets and a luxury suite at Raymond James Stadium, along with more than $400,000 spent on fine art.
The indictment seeks approximately $61.6 million from Tesar, about $3.19 million from Presha, and roughly $263,223 from Evans through criminal forfeiture allegations, although the government must meet applicable legal requirements before it can permanently forfeit disputed property.
Asset allegations provide another way to test the referral-loop theory, because investigators can compare the timing of Medicare payments, Primecare transfers, Company-I invoices, representative compensation, personal expenditures, and money movement among accounts or investment platforms.
Defendants and third parties may contest ownership, traceability, valuation, or the alleged connection between specific property and criminal proceeds, while seizure before trial does not itself establish that the assets were unlawfully acquired or that any defendant committed an offense.
The Charges and the Government’s Burden
Tesar faces five healthcare-fraud counts, one conspiracy count, and two counts alleging the offer and payment of healthcare kickbacks, while Presha and Evans face the conspiracy charge and separate counts accusing each man of receiving a prohibited kickback.
To prove healthcare fraud, prosecutors must establish a knowing and willful scheme involving materially false representations connected to a healthcare benefit program, leaving room for disputes over medical necessity, documentation responsibility, billing knowledge, reliance, causation, and intent.
The kickback allegations require proof that remuneration was knowingly and willfully offered, paid, solicited, or received to induce or reward referrals for federally reimbursable items or services, making the purpose behind the compensation more important than its contractual label.
Conspiracy law lets prosecutors present the alleged network collectively, but guilt remains individual, and each defendant may argue that personal communications, professional duties, commercial arrangements, patient interactions, or financial benefits did not show knowing participation in a shared unlawful objective.
The indictment is not evidence at trial, and the referral-loop narrative will become proof only if admissible testimony, records, expert opinions, financial analysis, and other evidence persuade a jury beyond a reasonable doubt regarding every required element.
A Case Emerging from a National Wound-Care Crackdown
The Tesar prosecution formed part of the Justice Department’s 2026 National Health Care Fraud Takedown, an enforcement initiative that announced charges against 455 defendants across dozens of federal districts involving more than $6.5 billion in alleged fraudulent claims.
Wound-care cases became a major feature of that operation because expensive skin substitutes created substantial financial incentives across manufacturers, distributors, marketers, referring professionals, and treating providers, particularly when compensation increased with product price or treated surface area.
The referral-loop model gives investigators several datasets to compare, including unusual provider volumes, patient overlap, product changes, repeated applications, failed wound improvement, sales contracts, percentage commissions, copayment patterns, beneficiary gifts, electronic communications, and bank transfers.
When those records align around the same patients and payment dates, prosecutors may argue that statistical abnormalities have acquired human intent, while defendants can still challenge whether investigators misunderstood legitimate treatment complexity, referral practices, or commercial compensation.
Compliance Lessons from the Alleged Patient Pipeline
Healthcare organizations can reduce comparable risk by prohibiting referral-based compensation, independently reviewing high-cost product use, auditing relationships among providers and distributors, and requiring documented clinical improvement before authorizing repeated applications or continuing costly wound-care protocols.
Compliance teams should examine whether supposed sales representatives actually perform documented commercial work, whether payments reflect fair market value, whether compensation varies with referred patient revenue, and whether clinicians know that colleagues have undisclosed financial interests in treatment decisions.
Beneficiaries and families can ask who recommended a provider, whether anyone receives compensation from the referral, what product will be used, why conservative treatment failed, how progress is measured, and what costs or gifts accompany the proposed care.
None of those questions establishes wrongdoing, and patients should never abandon necessary wound treatment without qualified medical guidance, but transparent answers can expose conflicts, improve informed consent, and help families distinguish patient-centered care from financially engineered utilization.
Public Allegations Create Consequences Before Verdicts
Major indictments rapidly enter search engines, professional databases, licensing discussions, business relationships, and international screening systems, producing reputational consequences long before a court determines whether the government’s allegations are accurate, incomplete, or legally insufficient.
The Amicus International Consulting news hub examines fraud investigations, asset seizures, extradition disputes, identity issues, and cross-border enforcement developments while emphasizing the essential distinction between allegations, convictions, civil findings, and unresolved criminal proceedings.
Organizations confronting intense public scrutiny may also review the principles outlined in Amicus International Consulting’s crisis communications and reputation-management guidance, including coordinated factual review, disciplined messaging, stakeholder communication, and careful responses to fast-moving media inquiries.
Responsible crisis communication should never obscure evidence, influence witnesses, mislead the public, or interfere with legal proceedings, but it can keep accurate procedural context, the presumption of innocence, and verified developments visible alongside sensational allegations.
What Comes Next in the Tesar Case
The litigation may involve extensive discovery, expert analysis of individual wounds, disputes over Medicare coverage rules, challenges concerning searches or statements, examination of electronic-message context, and forensic tracing of payments through businesses, banks, and investment accounts.
Medical experts could be asked whether specific grafts were necessary or futile, reimbursement specialists may explain coverage and coding, and financial witnesses may reconstruct whether distributor payments represented legitimate sales compensation or concealed rewards for patient referrals.
For prosecutors, the case’s power lies in the alleged alignment of patient sourcing, twenty-percent calculations, expensive product selection, clinical documentation, Medicare payments, and subsequent transfers, each component reinforcing the claimed existence of a coordinated commercial system.
For the defense, the task will be to break those connections by separating lawful nursing activity from inducement, legitimate sales work from referral compensation, disputed medical judgment from deliberate fraud, and ambiguous communications from proof of criminal intent.
Until evidence is tested and a verdict or other resolution occurs, the federal case remains a sweeping accusation that a trusted clinical pathway became a self-replenishing billing pipeline, while Tesar, Presha, and Evans remain legally presumed innocent.
